Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alprawin P 0.25mg/20mg Tablet

Prescription Icon
Prescription Required

Marketer

Mediwin Pharmaceuticals

Salt Composition

Alprazolam (0.25mg) + Propranolol (20mg)

Overview Alprawin P 0.25mg/20mg Tablet

Anxiolytic medication, Alprawin P 0.25mg/20mg tablets, requires a prescription. It manages anxiety by reducing overactive neuronal signaling in the brain, and also counteracts certain neurotransmitters' effects on cardiovascular function, thereby lowering heart rate and blood pressure. Administer Alprawin P on an empty stomach, consistently at the same time daily for optimal therapeutic levels. Follow your physician's prescribed dosage and duration precisely, due to its potential for dependence. Missed doses should be taken immediately upon recall. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation is inadvisable due to potential withdrawal. Alcohol consumption should be avoided as it may diminish efficacy. Common side effects include cognitive impairment (confusion, memory loss), bradycardia, fatigue, and nightmares. Drowsiness and dizziness are also possible; avoid activities demanding concentration until the drug's effects are known. Alprawin P can mask diabetic symptoms; regular blood glucose monitoring is essential. Report any significant edema (legs/ankles), rapid weight gain, or sudden dyspnea to your doctor immediately. Caution is advised for patients with hepatic impairment. Comprehensive disclosure of all concomitant medications is crucial, as interactions may affect Alprawin P's effectiveness or mechanism of action. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.

Primary Ingredients of Alprawin P 0.25mg/20mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Alprawin P 0.25mg/20mg Tablet

Generalized anxiety

Major Benefits of Alprawin P 0.25mg/20mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alprawin P 0.25mg/20mg tablets should be administered on an empty stomach.

Common Side effects of Alprawin P 0.25mg/20mg Tablet:

  • Confusion
  • Drowsiness
  • Memory impairment
  • Slow heart rate
  • Tiredness
  • Uncoordinated body movements
  • Nightmares
  • Cold extremities

How to use Alprawin P 0.25mg/20mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Alprawin P 0.25mg/20mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Alprawin P 0.25mg/20mg Tablet works:

Each Alprawin P 0.25mg/20mg tablet contains alprazolam, a benzodiazepine, and propranolol, a beta-blocker. Alprazolam enhances the effects of GABA, a neurotransmitter that dampens overactive brain cells. Propranolol counteracts specific chemical signals affecting the cardiovascular system, thereby lowering heart rate, blood pressure, and cardiac workload.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Alprawin P 0.25mg/20mg Tablet ingestion is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Alprawin P 0.25mg/20mg tablets is contraindicated during pregnancy due to established risks to fetal development. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Maternal use of Alprawin P 0.25mg/20mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving may be impaired by side effects of Alprawin P 0.25mg/20mg Tablets, such as visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, or drowsiness.

KidneyKidneySAFE IF PRESCRIBED

The use of Alprawin P 0.25mg/20mg tablets in patients with kidney disease is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Alprawin P 0.25mg/20mg tablets, as dosage modification may be necessary. Physician consultation is recommended. Routine blood pressure checks are advised to guide appropriate dosage.

What if you forget to take Alprawin P 0.25mg/20mg Tablet :

Should you forget to take a dose of Alprawin P 0.25mg/20mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alprawin P 0.25mg/20mg Tablet

LabelValue
Developing Habits Affirmative.
Treatment Category Neuroscience of the Central Nervous System
Alprawin P 0.25mg/20mg Ta...
16